TXNRD1 and rheumatoid arthritis: We selected auranofin, an FDA-approved treatment for rheumatoid arthritis, which has been shown to inhibit thioredoxin reductase 1, an antioxidant enzyme that acts on electron cycling in the NADPH/GSH electron coupling system (43–45).